HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of the anti-Thomsen-Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer.

AbstractPURPOSE:
The TF (Thomsen-Friedenreich, CD176, GalĪ²1-3GalNAc) carbohydrate moiety is known as a specific oncofetal carbohydrate epitope present in fetal and neoplastic tissue as well as in stem cells. TF was demonstrated to mediate tumor-promoting features and to be highly immunogenic. The current study aimed to evaluate whether presence of the TF antigen is associated with clinico-pathological parameters and prognosis of early breast cancer (BC).
METHODS:
Primary BC tissue (n = 226) was stained for TF using two monoclonal anti-TF antibodies (Nemod-TF1, Nemod-TF2). Staining results were correlated to clinical data including survival.
RESULTS:
Nemod-TF1 staining was positively correlated to lymph node metastasis (p = 0.03) and the presence of tumor-associated MUC1 (TA-MUC1; p = 0.003). Further, the presence of the Nemod-TF1 epitope predicted worse prognosis in TA-MUC1 positive (overall survival: p = 0.026) as well as in triple negative (overall survival: p = 0.002; distant metastasis-free survival: p = 0.012) BC.
CONCLUSIONS:
The data presented here further support a role of TF in BC tumor biology. Whether anti-TF directed treatment approaches may gain clinical relevance in those cases determined as triple negative or TA-MUC1 positive remains to be determined.
AuthorsSabine Heublein, Markus Egger, Junyan Zhu, Luisa Berger, Doris Mayr, Christian Schindlbeck, Christina Kuhn, Simone S Hofmann, Florian Schuetz, Udo Jeschke, Nina Ditsch
JournalBreast cancer research and treatment (Breast Cancer Res Treat) Vol. 179 Issue 3 Pg. 643-652 (Feb 2020) ISSN: 1573-7217 [Electronic] Netherlands
PMID31828591 (Publication Type: Journal Article)
Chemical References
  • Antibodies
  • Antibodies, Monoclonal, Humanized
  • Antigens, Neoplasm
  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor
  • MUC1 protein, human
  • Mucin-1
  • PankoMab-GEX
  • Thomsen-Friedenreich antigen
  • Thomsen-Friedenreich antibodies
Topics
  • Antibodies (immunology)
  • Antibodies, Monoclonal, Humanized (metabolism)
  • Antigens, Neoplasm (immunology)
  • Antigens, Tumor-Associated, Carbohydrate (immunology)
  • Biomarkers, Tumor (immunology)
  • Female
  • Humans
  • Immunohistochemistry
  • Lymphatic Metastasis (diagnosis, pathology)
  • Middle Aged
  • Mucin-1 (metabolism)
  • Prognosis
  • Triple Negative Breast Neoplasms (diagnosis, mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: